Viridian Therapeutics, Inc. (VRDN) quarterly cash flow statement — complete operating, investing & financing history
Viridian Therapeutics, Inc. (VRDN) cash flow statement — 14-year operating, investing & financing cash flows
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Cash from Operations | -224.98M | -119.65M | -23.75M | -84.61M | -75.37M | -92.65M | -73.33M | -67.71M | -46.06M | -45.22M | -38M | -38.98M | -45.21M | -61.97M | -34.04M | -20.67M | -18.09M | -21.04M | -16.54M | -11.88M |
| Operating CF Margin % | -79217.61% | -84860.99% | -17995.45% | -119.9% | -100497.33% | -128684.72% | -101850% | -78727.91% | -63969.44% | -62809.72% | -52777.78% | -54143.06% | -62797.22% | -63237.76% | -32420.95% | -1729.54% | -7064.84% | -9741.67% | -7726.64% | -5709.62% |
| Operating CF Growth % | -198.49% | -29.14% | 67.61% | -24.97% | -63.65% | -104.88% | -92.98% | -73.68% | -1.87% | 27.03% | -11.63% | -88.62% | -149.99% | -194.52% | -105.88% | -74.03% | -23.61% | -82.36% | -75.23% | -133.09% |
| Net Income | -232.02M | -104.9M | -120.36M | -34.6M | -100.73M | -86.91M | -79.72M | -76.69M | -64.99M | -48.54M | -66.86M | -47.66M | -55.06M | -68.15M | -45.78M | -28.91M | -29.49M | -25.69M | -28.95M | -14.04M |
| Depreciation & Amortization | 238K | 121K | -868K | 110K | 113K | 117K | 123K | -12.62M | 142K | 145K | 150K | 135K | 132K | 105K | 96K | 62K | 157K | 140K | 32K | 30K |
| Stock-Based Compensation | 30.37M | 13.39M | 11.99M | 11.25M | 10.84M | 10.22M | 8.97M | 8.72M | 11.77M | 12.69M | 26.05M | 13.61M | 12.3M | 15.22M | 5.28M | 4.94M | 0 | 0 | 3.49M | 3.98M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.07M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -919K | -6.87M | 4.13M | -1.04M | -1.46M | -2.22M | -3.17M | 19.05M | -4.1M | -4.56M | 112K | -981K | 2.11M | -2.88M | -888K | 313K | 5.09M | 4.88M | 7.93M | 1.25M |
| Working Capital Changes | -22.65M | -21.39M | 81.35M | -60.33M | 15.87M | -13.86M | 460K | -6.17M | 11.13M | -4.96M | 5.62M | -4.08M | -4.7M | -6.26M | 7.26M | 2.92M | 6.16M | -369K | 958K | -3.09M |
| Change in Receivables | 0 | 0 | 0 | -70M | 0 | 0 | 14K | -102K | 102K | 0 | 0 | 0 | 26K | -26K | 297K | 295K | -172K | -71K | 28K | 1.57M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -297K | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -574K | 4.63M | -1.38M | 1.55M | 4.63M | 1.76M | -3.92M | 2.93M | 438K | 482K | -1.52M | -108K | -3.77M | -6.65M | 1.75M | 8.05M | 1.7M | 31K | -1.41M | 1.46M |
| Cash from Investing | -153.9M | 77.26M | -339.42M | 126.08M | 75.72M | 100.06M | -62.91M | -84.67M | 61.98M | -143.04M | -169.71M | 48.04M | 40.71M | -13.29M | -180.6M | 42.65M | 13.96M | 8.86M | -80.21M | 6.25M |
| Capital Expenditures | -1.33M | -23K | -240K | -127K | -42K | -86K | -114K | -293K | -104K | 0 | -48K | -404K | -331K | -115K | -231K | -95K | -292K | -179K | -84K | -185K |
| CapEx % of Revenue | 467.96% | 16.31% | 181.82% | 0.18% | 56% | 119.44% | 158.33% | 340.7% | 144.44% | - | 66.67% | 561.11% | 459.72% | 117.35% | 220% | 7.95% | 114.06% | 82.87% | 39.25% | 88.94% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 169.66M | 0 | 0 | 0 | 180.37M | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -169.66M | 0 | 0 | 0 | -180.37M | 0 | 0 | 0 | 2K | 2K |
| Cash from Financing | 331.48M | 6.36M | 405.91M | 10.86M | 764K | 9.21M | 35.52M | 245.02M | 108K | 177.08M | 198.94M | 15.46M | 3.07M | 8.2M | 26.01M | 290.93M | 4.56M | 738K | 170K | 116.79M |
| Debt Issued (Net) | 195.3M | 0 | 28.88M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15M | 0 | 0 | 446K | 0 | 4.55M | 0 | 0 | 0 |
| Equity Issued (Net) | 151.95M | 6.36M | 327.49M | 9.96M | 1K | 4.94M | 33.65M | 233.75M | 108K | 186.26M | 201.26M | 0 | 0 | 0 | 25.09M | 266.79M | 4K | 738K | 1M | 104.71M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -15.78M | 0 | 49.54M | 897K | 763K | 4.27M | 1.88M | 11.27M | 0 | -9.18M | -2.32M | 457K | 3.07M | 8.2M | 482K | 24.15M | 0 | 0 | -834K | 12.09M |
| Net Change in Cash | -47.4M | -36.04M | 42.73M | 52.32M | 1.11M | 16.62M | -100.72M | 92.65M | 16.03M | -11.19M | -8.77M | 24.52M | -1.43M | -67.06M | -188.63M | 312.92M | 435K | -11.44M | -96.58M | 111.17M |
| Free Cash Flow | -226.31M | -119.68M | -23.99M | -84.74M | -75.42M | -92.74M | -73.45M | -68M | -46.16M | -45.22M | -38.05M | -39.39M | -45.55M | -62.09M | -34.27M | -20.76M | -18.38M | -21.22M | -16.62M | -12.06M |
| FCF Margin % | -79685.56% | -84877.31% | -18177.27% | -120.08% | -100553.33% | -128804.17% | -102008.33% | -79068.6% | -64113.89% | -62809.72% | -52844.44% | -54704.17% | -63256.94% | -63355.1% | -32640.95% | -1737.49% | -7178.91% | -9824.54% | -7765.89% | -5798.56% |
| FCF Growth % | -200.08% | -29.05% | 67.33% | -24.62% | -63.37% | -105.07% | -93.04% | -72.64% | -1.35% | 27.16% | -11.01% | -89.7% | -147.82% | -192.58% | -106.23% | -72.15% | -25.15% | -83.67% | -77.12% | -134.29% |
| FCF per Share | -2.10 | -1.17 | -0.28 | -1.04 | -0.92 | -1.14 | -0.92 | -1.02 | -0.72 | -0.74 | -0.77 | -0.90 | -1.05 | -1.47 | -0.85 | -0.62 | -0.66 | -0.81 | -1.49 | -1.08 |
| FCF Conversion (FCF/Net Income) | 1.77x | 1.14x | 0.20x | 2.45x | 0.75x | 1.07x | 0.92x | 0.88x | 0.71x | 0.93x | 0.57x | 0.82x | 0.82x | 0.91x | 0.74x | 0.72x | 0.61x | 0.82x | 0.57x | 0.85x |
| Interest Paid | 0 | 0 | 0 | 457K | 457K | 448K | 453K | 0 | 458K | 452K | 0 | 208K | 114K | 112K | 0 | 77K | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |